CreativeOne Wealth LLC lifted its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 24.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,410 shares of the financial services provider's stock after buying an additional 2,021 shares during the period. CreativeOne Wealth LLC's holdings in CME Group were worth $2,417,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in CME. Norges Bank bought a new position in shares of CME Group in the fourth quarter worth $1,107,389,000. Raymond James Financial Inc. acquired a new stake in CME Group in the fourth quarter worth about $871,063,000. Franklin Resources Inc. grew its position in CME Group by 70.4% in the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider's stock valued at $544,157,000 after buying an additional 1,003,119 shares in the last quarter. Capital Wealth Planning LLC increased its stake in CME Group by 69.2% during the 4th quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock valued at $565,671,000 after buying an additional 996,498 shares during the period. Finally, Egerton Capital UK LLP bought a new stake in shares of CME Group during the 4th quarter worth about $223,967,000. 87.75% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other CME Group news, insider Julie Winkler sold 11,592 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares of the company's stock, valued at $5,453,085.45. The trade was a 34.63 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares in the company, valued at $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 over the last ninety days. Corporate insiders own 0.30% of the company's stock.
CME Group Trading Up 0.4 %
Shares of CME stock traded up $1.14 during trading hours on Friday, reaching $262.53. 1,794,607 shares of the stock traded hands, compared to its average volume of 2,144,707. The business has a fifty day moving average price of $257.19 and a 200 day moving average price of $240.65. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $273.42. The firm has a market capitalization of $94.60 billion, a PE ratio of 27.15, a PEG ratio of 6.76 and a beta of 0.43.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. This is a boost from CME Group's previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 annualized dividend and a dividend yield of 1.90%. CME Group's payout ratio is presently 51.71%.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the stock. Piper Sandler increased their price objective on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Oppenheimer increased their price target on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research note on Friday, April 11th. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research note on Monday, March 10th. Bank of America upped their price objective on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Finally, Citigroup lowered CME Group from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and an average price target of $247.47.
View Our Latest Analysis on CME
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report